Patents by Inventor Stanley L. Hem

Stanley L. Hem has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10159750
    Abstract: The invention described herein pertains to compounds and conjugates, to compositions, complexes and formulations comprising the compounds and/or conjugates, and to methods of use of the compounds, conjugates and their compositions, complexes and formulations in vaccines and vaccinations and generating immune responses.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: December 25, 2018
    Assignee: PURDUE RESEARCH FOUNDATION
    Inventors: Richard Frederic Borch, Irene A. George, Harm Hogenesch, Stanley L. Hem
  • Publication number: 20180289820
    Abstract: The invention described herein pertains to compounds and conjugates, to compositions, complexes and formulations comprising the compounds and/or conjugates, and to methods of use of the compounds, conjugates and their compositions, complexes and formulations in vaccines and vaccinations and generating immune responses.
    Type: Application
    Filed: June 8, 2018
    Publication date: October 11, 2018
    Applicant: Purdue Research Foundation
    Inventors: Richard Frederic Borch, Irene A. George, Harm Hogenesch, Stanley L. Hem
  • Patent number: 10010616
    Abstract: The invention described herein pertains to compounds and conjugates, to compositions, complexes and formulations comprising the compounds and/or conjugates, and to methods of use of the compounds, conjugates and their compositions, complexes and formulations in vaccines and vaccinations and generating immune responses.
    Type: Grant
    Filed: January 27, 2012
    Date of Patent: July 3, 2018
    Assignee: PURDUE RESEARCH FOUNDATION
    Inventors: Richard Frederic Borch, Irene A. George, Harm Hogenesch, Stanley L. Hem, Lawrence E. Hem
  • Patent number: 4970079
    Abstract: Oxy-iron compounds are useful for the treatment and prevention of hyperphosphatemia. Such compounds, particularly those exhibiting high surface area, can be administered orally to bind and inhibit absorption of dietary phosphate, or such compounds can be contacted with the dialysate in a hemodialysis unit to enhance reduction of serum phosphate of patients undergoing hemodialysis.
    Type: Grant
    Filed: June 5, 1989
    Date of Patent: November 13, 1990
    Assignee: Purdue Research Foundation
    Inventors: Stanley L. Hem, Joseph L. White
  • Patent number: 4242328
    Abstract: Dried amorphous aluminum hydroxide gels having substantial acid reacting capability over an extended period of time are prepared by drying the gel after contacting the aqueous liquid gel with an inert organic solvent of sufficient solubility in water to replace water in the gel. The dried gel product and pharmaceutical compositions comprising the gel are also novel.
    Type: Grant
    Filed: September 4, 1979
    Date of Patent: December 30, 1980
    Assignee: Purdue Research Foundation
    Inventors: Stanley L. Hem, Joe L. White
  • Patent number: 4059681
    Abstract: Stable dried aluminum hydroxide gels possessing the high acid reactivity of liquid aluminum hydroxide gel are prepared by drying the gel from non-aqueous solvents.
    Type: Grant
    Filed: April 9, 1975
    Date of Patent: November 22, 1977
    Assignee: Purdue Research Foundation
    Inventors: Stanley L. Hem, Joe L. White